)
Specialized Medical Company (4019) investor relations material
Specialized Medical Company Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2026 revenue rose 4.8% YoY to 401.1 million, supported by higher patient activity and expanding outpatient operations.
9M 2026 revenue increased 4.6% YoY to 1,183.1 million, while EBITDA and net profit declined amid higher operating costs and lower other income.
Financial highlights
Q3 2026 EBITDA was 78.7 million, down 24.7% YoY; net profit was 41.9 million, down 36.8%.
9M 2026 EBITDA was 230.7 million, down 5.6% YoY; net profit was 119.6 million, down 9.5%.
Q3 revenue was 401.1 million versus 382.6 million in Q3 2025; 9M revenue was 1,183.1 million versus 1,130.9 million.
Outlook and guidance
Near-term priorities include ramping up Al Malqa clinic center and launching the MOH PPP mental health hospital, targeted to commence operations by Q2 2027.
SMC 3 and SMC 4 are estimated for completion in 2028; SMC 5 is estimated for 2029, with land acquisition expected in 2026.
Planned northern Riyadh hospitals are expected to nearly double capacity; the strategy also targets outpatient expansion and growth in higher-margin acute care services.
- Net profit rose 24.2% in Q2 2026, with margin gains and new hospital contracts supporting growth.4019
Q2 2026 - Q1 2026 delivered 3.3% revenue and 9.8% profit growth, with strong expansion and improved leverage.4019
Q1 2026 - FY 2025 net profit rose 43.7% to SAR 266.2m on 7% revenue growth, with strong 2026 outlook.4019
Q4 2025 - Q3 2025 net profit up 12.4%, with margin gains and major expansion projects underway.4019
Q3 2025 - Q2 2025 revenue up 6.6% YoY, IPO completed, and expansion continues despite margin pressure.4019
Q2 2025 - Net profit fell 40% on higher costs, with IPO and dividend reversals marking a pivotal quarter.4019
Q1 2025 - Revenue and net profit rose, dividend increased, and IPO planned for June 2025.4019
Q4 2024
Next Specialized Medical Company earnings date
Next Specialized Medical Company earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)